173 related articles for article (PubMed ID: 21818920)
1. Focal neuroendocrine differentiation in prostatic gland carcinoma with basaloid pattern.
Gligorijević JV; Velicković LV; Jancić SA; Radovanović Z; Krstić MS; Katić VV
Vojnosanit Pregl; 2011 Jun; 68(6):515-8. PubMed ID: 21818920
[TBL] [Abstract][Full Text] [Related]
2. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study.
Grignon DJ; Ro JY; Ordoñez NG; Ayala AG; Cleary KR
Hum Pathol; 1988 Dec; 19(12):1425-33. PubMed ID: 2461340
[TBL] [Abstract][Full Text] [Related]
3. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
[TBL] [Abstract][Full Text] [Related]
4. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
Yu DS; Hsieh DS; Chen HI; Chang SY
J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
[TBL] [Abstract][Full Text] [Related]
5. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
[TBL] [Abstract][Full Text] [Related]
6. Cells in various benign and malignant conditions of the human prostate express different antigenic phenotypes.
Turhan OI; Aydin NE; Sariyüce O; Ozkan S
Int Urol Nephrol; 1998; 30(6):731-44. PubMed ID: 10195869
[TBL] [Abstract][Full Text] [Related]
7. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis.
Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z
Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920
[TBL] [Abstract][Full Text] [Related]
8. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression.
Montironi R; Mazzucchelli R; Stramazzotti D; Scarpelli M; López Beltran A; Bostwick DG
J Clin Pathol; 2005 Mar; 58(3):290-6. PubMed ID: 15735163
[TBL] [Abstract][Full Text] [Related]
9. Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study.
Weaver MG; Abdul-Karim FW; Srigley J; Bostwick DG; Ro JY; Ayala AG
Am J Surg Pathol; 1992 Jan; 16(1):62-8. PubMed ID: 1370193
[TBL] [Abstract][Full Text] [Related]
10. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
11. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
Ding HY; Gao LX
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
[TBL] [Abstract][Full Text] [Related]
12. Unusual histologic types of high-grade prostatic intraepithelial neoplasia.
Reyes AO; Swanson PE; Carbone JM; Humphrey PA
Am J Surg Pathol; 1997 Oct; 21(10):1215-22. PubMed ID: 9331295
[TBL] [Abstract][Full Text] [Related]
13. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
Botticelli AR
Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
[TBL] [Abstract][Full Text] [Related]
14. Florid basal cell hyperplasia of the prostate.
van de Voorde W; Baldewijns M; Lauweryns J
Histopathology; 1994 Apr; 24(4):341-8. PubMed ID: 7519164
[TBL] [Abstract][Full Text] [Related]
15. Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Cussenot O; Villette JM; Valeri A; Cariou G; Desgrandchamps F; Cortesse A; Meria P; Teillac P; Fiet J; Le Duc A
J Urol; 1996 Apr; 155(4):1340-3. PubMed ID: 8632569
[TBL] [Abstract][Full Text] [Related]
16. NKX3.1 expression in cervical 'adenoid basal cell carcinoma': another gynaecological lesion with prostatic differentiation?
Stewart CJR; Moses J
Pathology; 2021 Feb; 53(2):193-198. PubMed ID: 33032811
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in basal cell carcinoma. An immunohistochemical study.
George E; Swanson PE; Wick MR
Am J Dermatopathol; 1989 Apr; 11(2):131-5. PubMed ID: 2469342
[TBL] [Abstract][Full Text] [Related]
18. Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.
Ather MH; Abbas F; Faruqui N; Israr M; Pervez S
BMC Urol; 2008 Dec; 8():21. PubMed ID: 19115997
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
Dema A; Tudose N
Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma of the prostate gland: a case report and brief review of the basal cell proliferations of the prostate gland.
Bohn OL; Rios-Luna NP; Navarro L; Duran-Peña A; Sanchez-Sosa S
Ann Diagn Pathol; 2010 Oct; 14(5):365-8. PubMed ID: 20850702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
